Tag: Gilead Sciences Inc

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

FDA vaccine head will step down in April after string of controversial decisions

Novartis, Genentech file suit alleging illegal importation of prescription drug

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive

Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations